Pharmacist-Led Intervention to Improve TB Treatment Adherence

Brief summary (registry, in English)

The goal of this clinical trial is to compare the adherence of co-morbid patients in control and experimental group The main question\[s\]it aims to answer are: 1. To evaluate the impact of pharmacist-led educational intervention on treatment adherence among patients with PTB using the health belief model theory and MARS-5. 2. To evaluate the impact of pharmacist-led educational intervention on treatment outcomes among patients with PTB. 3. To evaluate the impact of pharmacist-led educational intervention on HRQoL among patients with PTB. Participants will be interviewed to measure the level of adherence. If there is a comparison group: The enrolled patient will be counselled and educated by the pharmacist on the therapy and the benefits of adherence (Control group). Enrolled participants will be counselled and educated by pharmacist on the therapy and benefits of adherence. (Experimental group).

What you commit to

• Study type: Interventional
• Participants enrolled: 383
• From 1 Sept 2023 to the primary completion date, 1 Sept 2024
• 2 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 19 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.